Melo visits Edinburgh for the 2024 Division of Neuropsychology summit
Panel discussion hosted by Dr. Alistair Teager, answering audience questions on a range of topics related to digital health technology and neuropsychology.
Last week, the clinical leads from the Melo team had the opportunity to attend the annual Division of Neuropsychology (DoN) summit, held at the National Museum of Scotland in Edinburgh.
The two day conference was full of innovative and enlightening talks on a range of topics, from the implementation of policy guidelines, to discussions surrounding the implementation of digital health technology in neuropsychological practice.
A trip to Edinburgh Christmas markets after the end of Day 1.
Alongside this, it was a perfect opportunity to connect, and reconnect, with professionals across the field of neuropsychology. It was also an invaluable opportunity to discuss Melo with experts in the field, giving us further insights into the potential benefit of Melo.
Decently’s Tom Handy attended the conference, building his knowledge from the wide range of talks, opening up discussions about Melo, and connecting with interested and passionate professionals. We asked him what he thought about the experience:
“Having the opportunity to connect, learn from, and discuss current issues with likeminded professionals was invaluable not only to my own personal interests but to the ongoing development of Melo, a platform I am very passionate about. ”
Day 1 began with a powerful talk on the importance of considering culture within neuropsychological testing, followed by a presentation highlighting the effect that medical intervention can have on cognitive processing and the importance of conveying this information properly to people.
It was fantastic to listen to professionals who share our passion for helping others, and for changing the field for the better. A session of 10 lightning talks really drove this feeling home. Each 5 minutes in length, every presentation discussed a relevant topic in neuropsychology, ranging from technology developed to map functional areas of the brain, to supporting men in prison living with brain injury. It was clear from the get go that every attendee was extremely dedicated in driving the neuropsychological support forward.
Dr Stephen Mullin and Dr Alistair Teager presenting on the use of DHT’s to improve the assessment and analysis of behaviours that challenge.
On day 2, Melo featured in it’s own presentation, given by Dr. Alistair Teager and Dr. Stephen Mullin - Melo’s Clinical Safety Officer. It was a fantastic opportunity not only to share the knowledge that we have gained over the last few years, but to also encourage others who might have similar ideas to innovate within their field.
Alistair had this to say about their experience of presenting and sharing about Melo at the DoN:
“It was a pleasure to reflect on our initial work evaluating Melo, and to have the opportunity to share it with others at the British Psychological Society’s Division of Neuropsychology Summit in Edinburgh. ”
The presentation outlined Melo through it’s development, highlighting the steps taken to ensure the highest level of clinical safety and data protection required by NHS standards, as well as the work we have done to ensure that Melo is built with patient and public needs at it’s forefront.
